Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson’s Disease Patients
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052818 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Małgorzata Wojtkowska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioenergetics, Faculty of Biology, Adam Mickiewicz University, 61-614 Poznan, Poland. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DUB-Initiative of Excellence-Research University program conducted by Adam Mickiewicz University, Dean of the Faculty of Biology and Head of Department of Bioenergetics of Institute of Molecular Biology and Biotechnology, AMU Poznan, Poland.
Abstract (Originalsprache)
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders globally and leads to an excessive loss of dopaminergic neurons in the substantia nigra of the brain. Circulating cell-free DNA (ccf-DNA) are double-stranded DNA fragments of different sizes and origins that are released into the serum and cerebrospinal fluid (CSF) due to cell death (i.e., necrosis and apoptosis) or are actively released by viable cells via exocytosis and NETosis. Using droplet digital polymerase chain reaction (ddPCR), we comprehensively analyzed and distinguished circulating cell-free mitochondrial DNA (ccf mtDNA) and circulating cell-free nuclear DNA (ccfDNA) in the serum and CSF of PD and control patients. The quantitative analysis of serum ccf-DNA in PD patients demonstrated a significant increase in ccf mtDNA and ccfDNA compared to that in healthy control patients and a significantly higher copy of ccf mtDNA when compared to ccfDNA. Next, the serum ccf mtDNA levels significantly increased in male PD patients compared to those in healthy male controls. Furthermore, CSF ccf mtDNA in PD patients increased significantly compared to ccfDNA, and ccf mtDNA decreased in PD patients more than it did in healthy controls. These decreases were not statistically significant but were in agreement with previous data. Interestingly, ccf mtDNA increased in healthy control patients in both serum and CSF as compared to ccfDNA. The small sample size of serum and CSF were the main limitations of this study. To the best of our knowledge, this is the first comprehensive study on serum and CSF of PD patients using ddPCR to indicate the distribution of the copy number of ccf mtDNA as well as ccfDNA. If validated, we suggest that ccf mtDNA has greater potential than ccfDNA to lead the development of novel treatments for PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioenergetics, Faculty of Biology, Adam Mickiewicz University, 61-614 Poznan, Poland.
- Centre for Chemical Biology, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.
- Department of Gene Expression, Faculty of Biology Poznan, Adam Mickiewicz University, 61-614 Poznan, Poland.
- Department of Computational Biology, Faculty of Biology, Adam Mickiewicz University, 61-614 Poznan, Poland.
- Department of Neurology, Clinical Hospital of Poznan University of Medical Sciences, 60-355 Poznan, Poland.
- Department of Teaching Anaesthesiology and Intensive Therapy, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
ORCID-Profile: Natalia Karczewska, Bartosz Sokół
Förderung
- DUB-Initiative of Excellence-Research University program conducted by Adam Mickiewicz University
- Dean of the Faculty of Biology and Head of Department of Bioenergetics of Institute of Molecular Biology and Biotechnology, AMU Poznan, Poland
Zitieren
APA
Wojtkowska, M., Karczewska, N., Pacewicz, K., Pacak, A., Kopeć, P., Florczak-Wyspiańska, J., Popławska-Domaszewicz, K., Małkiewicz, T., & Sokół, B. (2024). Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson’s Disease Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052818
Vancouver
Wojtkowska M, Karczewska N, Pacewicz K, Pacak A, Kopeć P, Florczak-Wyspiańska J, et al. Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson’s Disease Patients. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052818
BibTeX
@article{Wojtkowska2024,
author = {Wojtkowska, Małgorzata and Karczewska, Natalia and Pacewicz, Klaudia and Pacak, Andrzej and Kopeć, Piotr and Florczak-Wyspiańska, Jolanta and Popławska-Domaszewicz, Karolina and Małkiewicz, Tomasz and Sokół, Bartosz},
title = {Quantification of Circulating Cell-Free DNA in Idiopathic Parkinson’s Disease Patients},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052818}
}
EUVIMED